MedTrace Logo

A Pharmaceutical Intervention to Reduce Drug-Related Problems in a Home Healthcare Program

NCT05820945 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2023-04-20

No results posted yet for this study

Summary

The investigators' hypothesis is that the individualized review of the pharmacotherapeutic plans of patients in a home healthcare program will be effective in improving the quality and safety of treatments. This study aims to evaluate the effectiveness of a standardized pharmaceutical intervention for the review and optimization of pharmacological treatments in ATDOM patients (catalan home healthcare program at primary care level), compared to the usual management.

Conditions

  • Polypharmacy
  • Potentially Inappropriate Medications

Interventions

OTHER

Pharmacist-led medication review

Clinical review by a primary care pharmacist of the primary care clinical history and the pharmacological treatment plan. After the review process, a meeting will be held between the pharmacist and the responsible physician in order to present proposals for pharmacotherapeutic optimization.

Sponsors & Collaborators

  • Institut Català de la Salut

    collaborator OTHER

  • University Rovira i Virgili

    collaborator OTHER

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    lead OTHER

Principal Investigators

  • Clara Salom Garrigues, Pharm · DAP Camp de Tarragona, Institut Català de la Salut.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2023-09-22
Completion
2024-03-22

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820945 on ClinicalTrials.gov